EURETINA 2022: Leadership discusses what to expect, outlines Women in Retina program

Conference|EURETINA

Dara Conlon, Executive Vice President of EURETINA, and Prof. Anat Loewenstein, General Secretary of EURETINA, discuss some key features of this year's Congress.

Related Videos
Related Content

Angiogenesis 2023: Innovative pharmacotherapies in spotlight

February 1st 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

The pros and cons of local resection of choroidal melanoma

December 18th 2022

What to expect from virtual AAO 2020

November 5th 2020

One of two widely used macular degeneration drugs outperforming other at weaning patients off treatment at one year, preliminary study shows

December 3rd 2022

Leaders in academic ophthalmology discuss AI for eye screening

November 16th 2022

Angiogenesis 2023: Innovative pharmacotherapies in spotlight

February 1st 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

The pros and cons of local resection of choroidal melanoma

December 18th 2022

What to expect from virtual AAO 2020

November 5th 2020

One of two widely used macular degeneration drugs outperforming other at weaning patients off treatment at one year, preliminary study shows

December 3rd 2022

Leaders in academic ophthalmology discuss AI for eye screening

November 16th 2022

Angiogenesis 2023: Innovative pharmacotherapies in spotlight

February 1st 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

The pros and cons of local resection of choroidal melanoma

December 18th 2022

What to expect from virtual AAO 2020

November 5th 2020

One of two widely used macular degeneration drugs outperforming other at weaning patients off treatment at one year, preliminary study shows

December 3rd 2022

Leaders in academic ophthalmology discuss AI for eye screening

November 16th 2022
Advertise
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.